Not finding it? Sign in to also search OpenAlex live.
-
OP0198 A SYSTEMATIC REVIEW TO INFORM THE EULAR POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY2020 Annals of the Rheumatic Diseases conference-abstract Mathematics Advanced Causal Inference Techniques Open access
Kim Lauper, Joanna Kedra, Martinus de Wit, Bruno Fautrel, Thomas Frisell, Kimme Leanne Hyrich, +12 more
1citations -
P22.14.A REPORTING STANDARDS IN RANDOMIZED CONTROLLED TRIALS WITH FAMILY CAREGIVERS IN NEURO-ONCOLOGY: A SYSTEMATIC REVIEW FROM THE RANO-CARES WORKING GROUP2024 Neuro-Oncology conference-abstract Decision Sciences Meta-analysis and systematic reviews Open access
Florien Willemijn Boele, Caroline Hertler, Paula R. Sherwood, David Cachia, Linda Dirven, Tobias Walbert, +3 more
0citations -
POS0535 QUERY ALGORITHMS AND MACHINE LEARNING METHODS AS TOOLS TO IDENTIFY COMORBIDITIES IN LARGE-SCALE FREE-TEXT BASED FIELDS: A CASE-REPORT2021 Annals of the Rheumatic Diseases conference-abstract Computer Science Machine Learning in Healthcare Open access
Dieter Roehrich, T. Maarseveen, Alfons A den Broeder, Călin D. Popa, Rachel Knevel
0citations -
P133 Filgotinib in patients with RA with inadequate response to methotrexate: FINCH 1 52-week efficacy and patient reported outcomes data2021 Lara D. Veeken conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Walker, Alan Kivitz, Yoshiya Tanaka, Susan Lee, Lei Ye, Hao Hu, +17 more
0citations -
Abstract 7325: Integration of functional data to classify BRCA1/2 missense variants: An ENIGMA project2024 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer
Paulo Cilas Morais Lyra Junior, Lucas Dalcolmo, Michael T. Parsons, Thales C. Nepomuceno, Samuel Gomes Brito, Nam Phuong N. Nguyen, +26 more
1citations -
Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT
Silvia Montoto, Jurgen H. E. Kuball, Jarl Mooyaart, Artak Ghandilyan, Dilyana Georgieva, Isabel Sánchez‐Ortega, +19 more
0citations -
Longer-term safety of pimicotinib in tenosynovial giant cell tumor (TGCT): Integrated analysis of phase 1 and phase 3 MANEUVER trial data.2026 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments
Hans A. J. Gelderblom, Vinod Ravi, Vishal Ghori, Aimar Zhang, Niki Karachaliou, Boyao Shan, +2 more
0citations -
A Bayesian Framework for Verifying Methane Inventories and Trends With Atmospheric Methane Data2023 conference-abstract Environmental Science Atmospheric and Environmental Gas Dynamics Open access
John R. Worden, Sudhanshu Pandey, Yuzhong Zhang, Daniel Cusworth, Zhen Qu, A. Anthony Bloom, +6 more
2citations -
POS1131 Prediction Models for Rheumatic Diseases: From Clinical Simplicity to Data-Driven Complexity with Patient-reported Symptoms for an Online Symptom Checker2025 Annals of the Rheumatic Diseases conference-abstract Health Professions Artificial Intelligence in Healthcare Open access
F. Zegers, Ling Qin, Daniyal Selani, Erik B. van den Akker, Ewout Willem Steyerberg, Rachel Knevel, +1 more
0citations -
Real-Life Data of Cyclosporine (CsA) Tapering in Patients with Very/ Severe Aplastic Anemia (v/sAA) Treated with Horse Anti-Thymocyte Globulin (hATG/CsA) Suggest Higher Risk of AA Relapse at Cyclosporine Plasma Levels below 100 Nanogram per Milliliter2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments
Jeanette Walter, Kim Kricheldorf, Yannic Schumacher, Susanne Isfort, Jörg Chromik, Beatrice Drexler, +4 more
2citations -
Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
Julia Marie Unglaub, Richard F. Schlenk, Maher Hanoun, Hans Christian Reinhardt, Jan Moritz Middeke, Kerstin Schäfer‐Eckart, +30 more
4citations -
Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.
Hans A. J. Gelderblom, Mathilde Jalving, Ingrid M.E. Desar, Omar Saavedra, Jourik A. Gietema, Stefan G. van Ravensteijn, +7 more
16citations -
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Matthias R. Zaiss, Kathrin Engelken, +11 more
7citations